Showing results (21-30 of 79) with videos related to
Sort By:
Pageof 8
Frontiers in Medicine|August 29, 2022
Impaired tryptophan metabolism in the gastrointestinal tract of patients with critical coronavirus disease 2019Yoshihiro Yokoyama, Tomoko Ichiki, Tsukasa Yamakawa, et al.Respiratory Investigation|January 13, 2026
Real-world clinical data on adult respiratory syncytial virus infection in a Japanese community hospital: Emphasis on positivity rate, older adults, and pneumonia casesHiroyuki Honda, Koji Kuronuma, Yutaro Nagano, et al.Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|March 27, 2022
Delayed dexamethasone treatment at initiation of oxygen supplementation for coronavirus disease 2019 is associated with the exacerbation of clinical conditionYuta Ibe, Tomoyuki Ishigo, Satoshi Fujii, et al.In Vivo (Athens, Greece)|March 4, 2022
Self-reported Smell and Taste Disorders in Patients With COVID-19: A Japanese Single-center StudyKeisuke Yamamoto, Yoshihiro Fujiya, Koji Kuronuma, et al.BMC Pulmonary Medicine|February 2, 2020
Surfactant protein A as a biomarker of outcomes of anti-fibrotic drug therapy in patients with idiopathic pulmonary fibrosisTakumi Yoshikawa, Mitsuo Otsuka, Hirofumi Chiba, et al.American Journal of Respiratory and Critical Care Medicine|August 28, 2014
Epidemiologic survey of Japanese patients with idiopathic pulmonary fibrosis and investigation of ethnic differencesMotoki Natsuizaka, Hirofumi Chiba, Koji Kuronuma, et al.American Journal of Physiology. Lung Cellular and Molecular Physiology|July 5, 2022
Role of transient receptor potential vanilloid 4 in therapeutic antifibrotic effects of pirfenidoneKoji Kuronuma, Mitsuo Otsuka, Masato Wakabayashi, et al.Canadian Respiratory Journal|September 7, 2018
Poorer Prognosis of Idiopathic Pleuroparenchymal Fibroelastosis Compared with Idiopathic Pulmonary Fibrosis in Advanced StageMakoto Shioya, Mitsuo Otsuka, Gen Yamada, et al.Frontiers in Microbiology|March 20, 2024
Gut microbiota and metabolites in patients with COVID-19 are altered by the type of SARS-CoV-2 variantYoshihiro Yokoyama, Tomoko Ichiki, Tsukasa Yamakawa, et al.BMC Pulmonary Medicine|January 3, 2024
The impact of respiratory reactance in oscillometry on survival in patients with idiopathic pulmonary fibrosisTatsuru Ishikawa, Hirotaka Nishikiori, Yuki Mori, et al.Pageof 8